Gale J - Search Results

1

The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat.

Clayton NM, Sargent R, Butler A, Gale J, Maxwell MP, Hunt AA, Barrett VJ, Cambridge D, Bountra C, Humphrey PP. Clayton NM, et al. Among authors: gale j. Neurogastroenterol Motil. 1999 Jun;11(3):207-17. doi: 10.1046/j.1365-2982.1999.00148.x. Neurogastroenterol Motil. 1999. PMID: 10354345

2

5-HT4 receptors are not involved in the control of small intestinal transit in the fasted conscious rat.

Clayton NM, Gale JD. Clayton NM, et al. Among authors: gale jd. Neurogastroenterol Motil. 1996 Mar;8(1):1-8. doi: 10.1111/j.1365-2982.1996.tb00236.x. Neurogastroenterol Motil. 1996. PMID: 8697180

3

GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.

Gale JD, Grossman CJ, Whitehead JW, Oxford AW, Bunce KT, Humphrey PP. Gale JD, et al. Br J Pharmacol. 1994 Jan;111(1):332-8. doi: 10.1111/j.1476-5381.1994.tb14064.x. Br J Pharmacol. 1994. PMID: 8012715 Free PMC article.

4

The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.

Gardner CJ, Twissell DJ, Dale TJ, Gale JD, Jordan CC, Kilpatrick GJ, Bountra C, Ward P. Gardner CJ, et al. Among authors: gale jd. Br J Pharmacol. 1995 Dec;116(8):3158-63. doi: 10.1111/j.1476-5381.1995.tb15118.x. Br J Pharmacol. 1995. PMID: 8719790 Free PMC article.

5

Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugs.

Bountra C, Gale JD, Gardner CJ, Jordan CC, Kilpatrick GJ, Twissell DJ, Ward P. Bountra C, et al. Among authors: gale jd. Oncology. 1996 Jun;53 Suppl 1:102-9. doi: 10.1159/000227649. Oncology. 1996. PMID: 8692545 Review.

6

Serotonergic mediation of vomiting.

Gale JD. Gale JD. J Pediatr Gastroenterol Nutr. 1995;21 Suppl 1:S22-8. doi: 10.1097/00005176-199501001-00008. J Pediatr Gastroenterol Nutr. 1995. PMID: 8708863 Review.

7

O'Hara BJ, Gale J, McGill B, Bauman A, Hebden L, Allman-Farinelli M, Maxwell M, Phongsavan P. O'Hara BJ, et al. Among authors: gale j. Am J Health Promot. 2017 Nov;31(6):491-501. doi: 10.1177/0890117116660776. Epub 2016 Aug 2. Am J Health Promot. 2017. PMID: 27485243

8

5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic system.

Kilpatrick GJ, Hagan RM, Gale JD. Kilpatrick GJ, et al. Among authors: gale jd. Behav Brain Res. 1996;73(1-2):11-3. doi: 10.1016/0166-4328(96)00063-0. Behav Brain Res. 1996. PMID: 8788470 Review.

9

GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity.

Gardner CJ, Armour DR, Beattie DT, Gale JD, Hawcock AB, Kilpatrick GJ, Twissell DJ, Ward P. Gardner CJ, et al. Among authors: gale jd. Regul Pept. 1996 Aug 27;65(1):45-53. doi: 10.1016/0167-0115(96)00071-7. Regul Pept. 1996. PMID: 8876035

10

Impact of the Make Healthy Normal mass media campaign (Phase 1) on knowledge, attitudes and behaviours: a cohort study.

Kite J, Gale J, Grunseit A, Bellew W, Li V, Lloyd B, Maxwell M, Vineburg J, Bauman A. Kite J, et al. Among authors: gale j. Aust N Z J Public Health. 2018 Jun;42(3):269-276. doi: 10.1111/1753-6405.12779. Epub 2018 Apr 12. Aust N Z J Public Health. 2018. PMID: 29644787 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

737 results

Search Page